Retrospective Study Provides Real-World Insight on Ide-cel in R/R Multiple Myeloma With Renal Impairment
Surbhi Sidana, MD, discusses the real-world safety and efficacy of ide-cel in patients with multiple myeloma and renal impairment, and emphasizes the importance of including this population in future clinical trials examining novel therapies in this disease.
Bristol Meyers Squibb Surbhi Sidana Bristol Myers Squibb Us Multiple Myeloma Car Consortium Division Of Blood Marrow Transplantation
Source: onclive.com